cetuximab,amivantamab-vmjw,lapatinib,rivoceranib
janssen,elevar therapeutics,eli lilly,jiangsu hengrui medicine
[]
#egfr amplified upper gi adenocarcinomas; an under recognized subset. #gi23 preclinical and pdx data being presented. also shoutout to our paper . #stcsm #esocsm 
Oncologist | Researcher | ColorectalCancer #CRCSM👨🏼‍🎓@MayoClinic @PittTweet Alum; 🧬#ctDNA #LiquidBiopsies💡#PrecisionOncology ViewsMy Own. COI @ASCO #ASCO22